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Carotid intimal-medial thickness (IMT) is used as a surrogate 
marker for atherosclerosis and can predict future clinical car-
diovascular events such as myocardial infarction and ischemic 
stroke [1]. Furthermore, medications for prevention of cardio-
vascular events including lipid-lowering [2], anti-hypertensive 
[3], and anti-platelet drugs [4,5] can decrease carotid IMT, 
which implicates that carotid IMT can also be used to assess 
the efficacy of anti-atherosclerotic treatment. 
  It is well documented that carotid IMT is markedly increased 
in subjects with high-cardiovascular disease risk such as those 
with diabetes [6], previous history of stroke [7] or myocardial 
infarction [8]. However, recent studies showed that subjects in 
the relatively low-risk group such as young subjects with obe-
sity [9,10] or impaired glucose tolerance [11] also had increased 
carotid IMT compared to that of normal controls. In those low-
risk subjects, glucose level significantly correlated with carotid 
IMT [10,12]. Non-diabetic subjects with parental history of 
diabetes or dyslipidemia also showed that disturbed carbohy-
drate metabolism is associated with carotid atherosclerosis 
[13,14]. In contrast, control of postprandial hyperglycemia by 
medication can regress carotid atherosclerosis [15]. 
  Insulin resistance and inflammation might play an impor-
tant role in the link between glucose abnormalities and carotid 
atherosclerosis [16,17]. Agewall et al. [18] showed a significant 
correlation between insulin sensitivity directly-assessed by 
clamp-study and carotid IMT in non-diabetic subjects. In-
flammatory markers such as C-reactive protein [19,20] and 
TNF-α [21] are also significantly correlated with carotid IMT.
History of gestational diabetes (GDM) is a risk factor of diabe-
tes mellitus and is also characterized by insulin resistance 
[22,23]. Ku et al. [24] were unable to show a significant differ-
ence in carotid IMT according to history of GDM; however, 
they did show that glucose level in the postpartum period is 
significantly associated with carotid IMT in subjects with a 
previous history of GDM. This result shows agreement with 
previous studies focusing on other risk groups such as subjects 
with parental history of diabetes, obesity or dyslipidemia [13, 
14]. 
  Considering the association between glucose abnormality 
and carotid atherosclerosis, screening and management of 
glucose abnormality in subjects with history of GDM is re-
quired. In addition, the significantly high risk of cardiovascu-
lar disease in subjects with history of GDM [22,23] calls for 
the concomitant management of other cardiovascular risk fac-
tors in such patients. However, considering cost, selection of a 
high risk group for future cardiovascular events might be re-
quired, and carotid IMT can provide such evidence. A prospec-
tive study to confirm the longitudinal association between 
glucose control and carotid IMT in subjects with a history of 
GDM and usefulness of carotid IMT is required. 
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